Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer
Authors:
- Weihan YangWYWeihan Yang
- Yu WangYWYu Wang
- Wenjing OuWOWenjing Ou
- Qingping MaQMQingping Ma
- Chuanjiang YuCYChuanjiang Yu
- Jiang RenJRJiang Ren
- Guoxing ZhongGZGuoxing Zhong
- Huashan ShiHSHuashan Shi
- Zhu YuanZYZhu Yuan
- Xiaolan SuXSXiaolan Su
- Wen ZhuWZWen Zhu
- 1 November 2012
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 31 (1) , 33-42
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 44 references indexed in Scilit:
- Apoptosis‐Inducing High .NO Concentrations Are Not Sustained Either in Nascent or in Developed CancersChemMedChem, 2008
- iNOS as a therapeutic target for treatment of human tumorsNitric Oxide, 2008
- Advances in Chemotherapy of Non-small Cell Lung CancerChest, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- High expression of nitric oxide synthases is a favorable prognostic sign in non‐small cell lung carcinomaAPMIS, 2003
- Role of nitric oxide in carcinogenesis and tumour progressionThe Lancet Oncology, 2001
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- Therapy of cancer metastasis by activation of the inducible nitric oxide synthaseCancer and Metastasis Reviews, 1998
- Nitric Oxide Synthase Activity in Human Lung CancerJapanese Journal of Cancer Research, 1997
- Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse MacrophagesScience, 1992